Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AME✓SelectedUSD · AMEGSK vs AME performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs AME

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.3%
AME return
+15.7%
Excess return
-8.4%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioAMEExcessAlpha
1D-0.1%-3.6%+3.4%+0.1%
7D-5.3%-7.9%+2.6%-4.9%
30D-3.7%-10.9%+7.3%-3.2%
3M-7.3%-6.6%-0.6%-7.6%
6M-4.2%-0.5%-3.7%-7.5%
YTD+0.9%+9.1%-8.2%-7.7%
1Y+7.3%+18.0%-10.7%-8.5%
All+7.3%+15.7%-8.4%-8.5%

Cumulative growth

Daily Returns

Daily percentage return beside AME.

Daily Out/Under-Performance

Portfolio return minus AME return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded AME wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling